Skip to main content

Abingworth LLP

SEC CIK
0001397144
Latest filing
Feb 10, 2023

Holdings in Q4 2022

Holdings as of Dec 31, 2022, filed Feb 10, 2023. Long positions only; changes compare share counts with Q3 2022.

Institution overview
Positions
19
0 vs. Q3 2022
Portfolio value
$303.5M
+$11.0M (+3.8%) vs. Q3 2022
Filed
Feb 10, 2023
SEC
Holdings of Abingworth LLP in Q4 2022
SecurityClassSharesValue% of portfolioShare changeActionHistory
PCVXVaxcyte, Inc.COM2,019,057$96.8M31.9%−2,149,661−51.6%ReducedHistory
VRNAVerona Pharma plcSPONSORED ADS2,457,500$64.2M21.2%00.0%UnchangedHistory
VERAVera Therapeutics, Inc.CL A2,960,231$57.3M18.9%00.0%UnchangedHistory
HLVXHilleVax, Inc.COM1,838,486$30.8M10.1%00.0%UnchangedHistory
ACETAdicet Bio, Inc.COM2,115,385$18.9M6.2%00.0%UnchangedHistory
PHATPhathom Pharmaceuticals, Inc.COM1,435,106$16.1M5.3%00.0%UnchangedHistory
OKUROnKure Therapeutics, Inc.COM2,073,957$4.83M1.6%00.0%UnchangedHistory
JSPRJasper Therapeutics, Inc.COM5,628,558$2.72M0.9%00.0%UnchangedHistory
SLNOSoleno Therapeutics IncCOM1,201,506$2.38M0.8%00.0%UnchangedHistory
NCNANuCana plcSPONSORED ADR3,333,333$2.20M0.7%00.0%UnchangedHistory
EFTReFFECTOR Therapeutics, Inc.COM4,822,114$2.06M0.7%00.0%UnchangedHistory
SPRBSpruce Biosciences, Inc.COM1,792,518$1.97M0.6%00.0%UnchangedHistory
PRTKParatek Pharmaceuticals, Inc.COM1,041,131$1.95M0.6%00.0%UnchangedHistory
CBAYCymaBay Therapeutics, Inc.COM131,036$821.6K0.3%00.0%UnchangedHistory
XCURExicure, Inc.COM NEW281,636$323.9K0.1%00.0%UnchangedHistory
SYRESpyre Therapeutics, Inc.COM240,500$108.2K<0.1%00.0%UnchangedHistory
MTEMMolecular Templates, Inc.COM200,000$66.0K<0.1%00.0%UnchangedHistory
OBSVObsEva SACOM87,999$12.8K<0.1%00.0%UnchangedHistory
SIENProject Sage Oldco, Inc.COM1,673,589––00.0%UnchangedHistory